1GA
WST icon

1st Global Advisors’s West Pharmaceutical WST Stock Holding History

1st Global Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$281K Buy
+2,978
New +$274K 0.03% 384

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

1st Global Advisors's WST Position: Q2 2017 in Review

1st Global Advisors opened a new position in West Pharmaceutical (WST) in Q2 2017: 2,978 shares worth $281K. The stake represents 0.03% of the portfolio and ranks #384 among its holdings.

309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

  • 1st Global Advisors held 2,978 shares of West Pharmaceutical worth $281K as of Q2 2017.
  • West Pharmaceutical was a new 1st Global Advisors position in Q2 2017.
  • West Pharmaceutical made up 0.03% of 1st Global Advisors's portfolio in Q2 2017, its #384 holding.
  • 309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.